两连板澳洋健康：不存在应披露而未披露的重大事项

Core Viewpoint - The company, Aoyang Health, announced that there are no undisclosed significant matters that should have been disclosed, following a significant stock price fluctuation over two consecutive trading days [1] Group 1: Stock Performance - Aoyang Health's stock price experienced an abnormal fluctuation, with a cumulative price increase exceeding 20% over the trading days of June 9 and June 10, 2025 [1] - The company confirmed that the information previously disclosed does not require correction or supplementation [1] Group 2: Company Operations - The company stated that its current operational situation is normal, and there have been no significant changes in the internal or external operating environment [1] - Aoyang Group, the controlling shareholder, and the actual controller, Mr. Shen Xueru, have not engaged in any buying or selling of the company's stock during the period of abnormal price fluctuation [1]